The Hamman-Rich syndrome following treatment of lymphoma with chlorambucil
Journal of the Louisiana State Medical Society official organ of the Louisiana State Medical Society 127(8): 311-315
1975
ISSN/ISBN: 0024-6921 PMID: 1176806 Document Number: 89391
Document emailed within 1 workday
Related Documents
Kurkova, R.A.; Bezrukova, M.M. 1973: Hamman-Rich syndrome Vrachebnoe Delo 8: 16-17Lebedev, S.P. 1983: Hamman-Rich syndrome Arkhiv Patologii 45(3): 73-76
Selivonenko, V.G.; German, A.K. 1971: Hamman-Rich syndrome Vrachebnoe Delo 10: 93-94
Volosianko, B.M.; Stakhevich, G.A.; Bakaliuk, P.M.; Kupnovitskaia, I.G.; Bigar, P.V. 1982: 2 cases of the Hamman-Rich syndrome Terapevticheskii Arkhiv 54(4): 130-131
Plascencia Moncayo, N.; Ramírez Soto, E.; Marcushamer, B. 1976: Hamman-Rich syndrome and pregnancy. Report of a case Ginecologia y Obstetricia de Mexico 39(233): 229-233
Pigoń, W.; Tyszkiewicz, S. 1976: Biventricular endocardial fibroelastosis in a case of Hamman-Rich syndrome Pediatria Polska 51(6): 715-720
Popov, N.; Strumeliev, S. 1982: Diffuse idiopathic interstitial pulmonary fibrosis (Hamman-Rich syndrome) Vutreshni Bolesti 21(6): 96-101
Popov, N.; Strumeliev, S. 1982: Diffuse idiopathic interstitial pulmonary fibrosis (Hamman-Rich syndrome) Vutreshni Bolesti 21(6): 96-101
Il'kovich, M.M.; Karpenkova, N.I.; Movchan, N.S.; Ivanova, N.M.; Novikova, L.N. 1982: Clinico-immunological correlations in idiopathic fibrosing alveolitis (Hamman-Rich syndrome) Klinicheskaia Meditsina 60(11): 74-78
Smirnov, I.P.; Khlopotova, G.P. 1974: Hamman-Rich disease Terapevticheskii Arkhiv 46(1): 72-78
Jaksić, B.; Brugiatelli, M. 1988: High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCi CLL-01 trial Nouvelle Revue Francaise d'Hematologie 30(5-6): 437-442
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Portlock, C.S.; Fischer, D.S.; Cadman, E.; Lundberg, W.B.; Levy, A.; Bobrow, S.; Bertino, J.R.; Farber, L. 1987: High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma Cancer Treatment Reports 71(11): 1029-1031
Goodwin, S. 1996: Data rich, information poor (DRIP) syndrome: is there a treatment? Radiology Management 18(3): 45-49
Abdou, A.G.; Kandil, M.; Eldien, M.S.; Abdallah, R. 2016: Splenic histiocyte-rich pseudotumor following chemotherapy for non Hodgkin diffuse large B cell lymphoma Pathologica 108(3): 140-143
Alliot, C.; Claisse, J.F.; Desablens, B. 1995: Tumor lysis syndrome in chronic lymphoid leukemia treated with chlorambucil and prednisone Presse Medicale 24(25): 1178
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Alatas, H.; Wirya, I.G.; Tambunan, T.; Himawan, S. 1978: Controlled trial of chlorambucil in frequently relapsing nephrotic syndrome in children (a preliminary report) Journal of the Medical Association of Thailand 61 Suppl. 1: 222-228
Brouhard, B.H. 1998: Should cyclosporine replace cytoxan or chlorambucil as the second-line drug for steroid-dependent nephrotic syndrome? Seminars in Nephrology 18(3): 367-369
Mehra, R.; Moore, T.L.; Catalano, D.; Neucks, S.H.; Zuckner, J. 1981: Chlorambucil in the treatment of iridocyclitis in juvenile rheumatoid arthritis Journal of Rheumatology 8(1): 141-144